← Browse by Condition
Medical Condition

fluid overload

Total Trials
5
Recruiting Now
5
Trial Phases
Phase 4

ClinicalMetric tracks all active clinical trials for fluid overload sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — fluid overload Clinical Trials

How many clinical trials are currently recruiting for fluid overload?
ClinicalMetric currently tracks 5 actively recruiting clinical trials for fluid overload, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 5. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for fluid overload?
fluid overload research spans Phase 4 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a fluid overload clinical trial?
Eligibility criteria for fluid overload trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 4
1
Top Sponsors
St. Jude Children's Research Hospital 1 trial
Karolinska University Hospital 1 trial
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 1 trial
Morten H. Bestle 1 trial
Nazmy Edward Seif 1 trial

Recruiting Clinical Trials

NCT07834710
Recruiting
Using Bioimpedance Analysis to Monitor Fluid Status in Children
Enrollment
30 pts
Location
United States
Sponsor
St. Jude Children's Research H...
View Trial →
NCT03629977
Recruiting
Timing of Renal Replacement Therapy in the Critically Ill Patients
Enrollment
50,000 pts
Location
Sweden
Sponsor
Karolinska University Hospital
View Trial →
NCT07275658
Recruiting
Timing and Dose of Fluid Deresuscitation in Critically Ill Patients
Enrollment
150 pts
Location
Netherlands
Sponsor
Academisch Medisch Centrum - U...
View Trial →
NCT04180397 Phase 4
Recruiting
Controlled Fluid Removal in Critical Ill Patients With Fluid Overload in the Intensive Care Unit.
Enrollment
1,000 pts
Location
Australia, Czechia, ...
Sponsor
Morten H. Bestle
View Trial →
NCT07626151
Recruiting
Electric Cardiometry-Guided Standard Versus Restricted Fluid Therapy In Robotic Prostaectomy
Enrollment
90 pts
Location
Egypt
Sponsor
Nazmy Edward Seif
View Trial →

Related Conditions

acute kidney injury (1) uremia (1) dialysis complications (1) critical illness (1) critical care intensive care (1) deresuscitation (1) prostate cancer (1) surgery (1) lactate blood increase (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology